Fairfield Financial Advisors, LTD Bluebird Bio, Inc. Transaction History
Fairfield Financial Advisors, LTD
- $340 Billion
- Q2 2024
A detailed history of Fairfield Financial Advisors, LTD transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Fairfield Financial Advisors, LTD holds 60 shares of BLUE stock, worth $30. This represents 0.0% of its overall portfolio holdings.
Number of Shares
60Holding current value
$30% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BLUE
# of Institutions
162Shares Held
79.9MCall Options Held
525KPut Options Held
634K-
Black Rock Inc. New York, NY15.4MShares$7.72 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.3MShares$5.15 Million0.0% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN6.39MShares$3.2 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny5.15MShares$2.57 Million0.0% of portfolio
-
Pictet Asset Management Sa Geneva 73, V84.67MShares$2.33 Million0.02% of portfolio
About bluebird bio, Inc.
- Ticker BLUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,121,800
- Market Cap $38.6M
- Description
- bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...